Sepsis is characterized by severe organ failure due to an impaired response to infection. The underlying pathophysiology of sepsis is characterized by concurrent unbalanced hyperinflammatory and immunoparalysis. This study aimed to identify new key biomarkers that could predict outcomes in sepsis patients and explore theirunderlying molecular mechanisms. Bulk transcriptome data (GSE65682, GSE28750, GSE57065, GSE95233) and scRNA-seq data (GSE167363) of sepsis were obtained from the GEO database. Data for MR analysis were sourced from the eQTLGen Consortium and IEU OpenGWAS project. Prognostic biomarkers and potential drug targets for sepsis were identified through univariate Cox regression and MR analysis. The expression of these biomarkers was further validated using scRNA-seq data to investigate the underlying molecular mechanisms. Significantly higher expression of CHIT1 was found at sepsis non-survivor and associated with 28-day mortality of sepsis. scRNA-seq data of septic samples found that CHIT1 mainly expressed in neutrophils, which was also higher in sepsis non-survivors. The CHIT1 + neutrophils expressed higher inflammation related genes of S100A8, S100A9, S100A11, S100A12, IL1R2, IFNGR2, TLR2 and CXCL8 and reduced expression of HLA related genes of HLA-DMA, HLA-DPA1, HLA-DPB1, HLA-DRA, HLA-DRB1 and HLA-DRB5. Moreover, cell-chat analysis also showed that CHIT1 + neutrophils could interact with other immune cell types, including NK cells, erythroid cells, monocytes/macrophages, and DC by the way of ICAM1-(ITGAM + ITGB2) pathway. We identified CHIT1 as new biomarker and potential drug target for sepsis, which may intensify hyperinflammation and immune suppression of neutrophils. Developing immunotherapeutic strategies aimed at targeting CHIT1 would help to enhance sepsis outcomes.
Clearing dying cardiomyocytes by efferocytosis is required for inflammation resolution and cardiac repair after myocardial infarction (MI). Whether the three functional stages of efferocytosis (recognition, engulfment and degradation) are coordinated by the local cellular neighborhood in the human infarcted myocardium is unknown. We analyzed 24 human cardiac Visium spatial transcriptomic samples (20 MI, 4 control; 94,029 spots; 19 independent donors) from a published multi-omic map of human MI[4]. Multiview interaction-based spatial transcriptomics (MISTy) identified 12 gene programs with spot-level neighborhood dependency; donor-level aggregation showed positive neighborhood gains for 22 of 23 programs after Benjamini-Hochberg correction (FDR < 0.05), including all three efferocytosis stages[5]. Efferocytosis module activity tracked macrophage proportions (Spearman rho = 0.41-0.44). Controlling for macrophage abundance removed the engulfment-related association but left a degradation-related association with endothelial and fibroblast proportions, indicating niche-dependent regulation of the degradation stage. Distance-stratified analysis showed neighborhood effects beyond direct cell-cell contact, without simple short-range dominance. Mendelian randomization linked NR1H3, STAU1, CTSS and ITGAV expression to MI risk (FDR < 0.05)[14], and connectivity-map analysis nominated niclosamide as a candidate for reversing the efferocytosis-degradation program[15]. Model-based in silico perturbation attributed the neighborhood dependency to vascular-stromal neighbors; virtual knockout of NR1H3 predicted coordinated downregulation of efferocytosis genes. Efferocytosis subprograms are thus spatially decoupled in the human infarcted myocardium, with degradation as a niche-regulated step, providing spatial and genetic leads for targeting infarct repair.
Stress granules (SGs) are cytosolic ribonucleoprotein condensates that control translation of stress-responsive mRNAs and are increasingly linked to cardiovascular inflammation. How their spatiotemporal behaviour relates to efferocytosis during myocardial infarction (MI) remains poorly defined. We analysed 42 core SG genes and 144 efferocytosis-related genes across public multi-omics datasets: a mouse MI single-nucleus RNA sequencing and Visium spatial transcriptomic time series (GSE214611), an independent spatial cohort (GSE265828), the FinnGen R11 MI genome-wide association study, GTEx v10 tissue eQTLs, the LINCS L1000 perturbation compendium, and SG-fraction and G3bp1-knockout RNA-seq data (GSE263848 and GSE264134). Zone-stratified analysis showed coordinated upregulation of SG and efferocytosis programs in the infarct zone at day 3 (72 h; 10 SG and 32 efferocytosis genes) and day 7 (168 h; 11 SG and 34 efferocytosis genes), with a significant zone-by-time interaction for 312 genes, including G3bp1 and 36 efferocytosis genes. Macrophages carried most of the efferocytosis program, which was acutely suppressed at 1 h and recovered between 4 h and day 3. Macrophages with a high SG program showed consistent SG-gene upregulation at both cell and animal levels. In an independent SG-fraction RNA-seq dataset, 61 of 144 efferocytosis mRNAs, including Lrp1, Mertk and Mfge8, were enriched in SG fractions, supporting SG-mediated sequestration of efferocytosis transcripts. SG (ATXN2) and efferocytosis (APOE, LIPA) loci carried genome-wide significant MI signals, and all 42 SG genes were eQTL genes in the coronary artery. HSP90 inhibitors were associated with elevated SG-related expression scores in L1000 screening. These findings define a cross-cohort transcriptomic map of SG-efferocytosis programs in MI and support the hypothesis that ischaemic stress, SG assembly and efferocytosis regulation are temporally coordinated.